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INTRODUCTION
Recent studies in adults have demonstrated the deleter-
ious effects of hyperglycemia in intensive care patients and
its substantial impact on crucial outcomes such as mortality.
As a result, there is an increasing interest in the impact of
this complication on the outcomes of critical illness in
children.1
Hyperglycemia is prevalent among critically ill children
and may be associated with poor outcomes and higher
morbidity during hospitalization.2 Few prospective studies
have analyzed the occurrence of hyperglycemia and the use
of intensive insulin therapy in critically ill children. A recent
single-center trial demonstrated the efficacy and safety of an
insulin therapy protocol. The trial results indicated
improved survival rates among the patients who received
the treatment.3
A clear association between hyperglycemia and poorer
outcomes has been demonstrated in some specific clinical
situations, such as septic shock, cardiac surgery, and
traumatic brain injury.4-7 However, hyperglycemia has yet
to be fully studied in the context of pediatric surgery, and no
pediatric neurosurgical studies have analyzed the associa-
tion between hyperglycemia, morbidity, and mortality.
This study evaluated the postoperative glucose levels
of children who underwent neurosurgeries for different
indications and analyzed the association of these levels with
lengths of mechanical ventilation, intensive care, and
hospital stay.
MATERIAL AND METHODS
The study was conducted in the Pediatric Intensive Care
Unit (PICU) of Santa Catarina Hospital, Sao Paulo, Brazil, a
tertiary multidisciplinary hospital with 16 PICU beds. This
retrospective cohort study evaluated all patients admitted to
the PICU who underwent neurosurgical procedures from
May 2004 to May 2009. Both plasma and capillary blood
glucose values were collected from patients during their
stay in the PICU and during their stay in the pediatric ward
after transfer from the PICU. Hyperglycemia was defined as
a blood glucose level $150 mg/dL. The three outcomes
evaluated in the study were the durations of mechanical
ventilation, PICU, and hospital stay. Hyperglycemia was
studied along with other likely risk factors in these patients,
such as fever, laryngitis, infection, hypothermia, packed red
blood cells, and hormonal disorders. First, a univariate
analysis was performed to identify the main risk factors
associated with the three outcomes, and the statistically
relevant risk factors were separated and analyzed in a
multivariate analysis. The level of significance was set at 5%.
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) 18.0 (Chicago,
Illinois). The study was approved by the Ethics in
Research Committee of the institution where it was
conducted.
RESULTS
The charts of 198 patients were analyzed during the
study. The most frequent surgeries were brain tumor
resection (37.4%), craniosynostosis (31.3%), ventriculoper-
itoneal shunting (16.7%), craniotomy for craniofacial dysos-
tosis (4.5%), spinal arthrodesis (4%), epilepsy surgery (2%),
and brain revascularization for Moyamoya disease (1.5%).
A total of 139 glucose measurements were recorded for
the patients included in the study. Hyperglycemia was
diagnosed in 62.6% of the patients. The patient glucose level
upon admission to the PICU and the highest glucose level
noted in the first 24 hours post-admission were recorded.
The mean glucose level was recorded following the 24-hour
measurement. The results of the glucose measurements
according to surgical diagnosis are listed in Table 1.
A univariate analysis identified a positive association
between hyperglycemia and a prolonged duration of PICU
stay (3.88 days vs. 2.46 days, p= 0.042). However, hypergly-
cemia was not associated with prolonged hospitalization or
the duration of mechanical ventilation required (Table 2).
The multivariate analysis did not identify any positive
associations between hyperglycemia and any of the three
outcomes studied (Table 3).
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DISCUSSION
To the best of our knowledge, the present study is the first
to analyze the effects and the incidence of hyperglycemia in
a pediatric neurosurgery environment. The highest glucose
levels were found in patients that underwent surgery for
craniosynostosis, supratentorial tumor resection, and cra-
niotomies; these procedures are more likely to involve
longer surgical times and higher incidence of complications,
such as bleeding and infection. These higher incidences
of complications increase the risk of hyperglycemia.
Univariate analysis indicated an association between
hyperglycemia and prolonged duration of stay in the
PICU. However, no association was found between hyper-
glycemia and the total duration of hospital stay or the length
of mechanical ventilation time required. Multivariate
analysis indicated no statistically relevant associations
between hyperglycemia and any of the outcomes. The
occurrence of severe hyperglycemia (above 300 mg/dL)
was rare.
Hyperglycemia is common in critical illness as a
consequence of organic stress and counter-regulatory
hormones and is typically interpreted as a secondary event
in critical care. Several studies have tried to identify an
association between hyperglycemia and a worse prognosis
in children, but their findings should be interpreted as
markers of severe illness. As the patient’s condition
improves, it is likely that their glucose levels will revert to
the normal range. As a secondary event, patients with other
complications that may affect glucose levels, either directly
or indirectly, such as fever, infection or bleeding, are more
likely to develop hyperglycemia and, consequently, worse
outcomes such as a prolonged ICU stay. Such factors may
explain why hyperglycemia was found to be associated with
a prolonged stay in the PICU in the univariate but not in the
multivariate analysis.
Up to 50% of pediatric patients who undergo neuro-
surgeries may develop several postoperative complica-
tions,8 and hyperglycemia is an important event that may
impact on their clinical course. Stress hyperglycemia is
associated with insulin resistance and frequently affects
adults and children. Some of the factors that may
contribute to stress hyperglycemia are high glucose
infusion rates, the increase in the production of endogen-
ous glucose due to action of the counter-regulatory
hormones (cortisol, glucagon, and catecholamine), and
changes in glucose transport.9
Changes in insulin counter-regulatory hormones due to
surgical stress have not been clearly defined; therefore, the
highest glucose level within the first 24 hours following
surgery was analyzed separately from the glucose level at
admission. There was a progressive reduction in glucose
levels in all surgical groups during the course of hospita-
lization. Mild hyperglycemia was identified and its rapid
progression to normal levels may be explained by the low
preoperative morbidity of the population studied, as most
procedures were elective and performed in patients with a
low anesthetic risk. According to this hypothesis, the
patients were more likely not to present the main
consequences of severe hyperglycemia, such as osmotic
diuresis, dehydration, and metabolic disorders. When
considering the results of the entire study population,
hyperglycemia was not severe enough in this scenario to
cause adverse effects and outcomes related to this metabolic
disorder.
It was not possible to evaluate the correlation between
hyperglycemia and mortality because only two deaths
occurred during the study. Nearly 59% of the patients
received one or more doses of systemic corticosteroids
during surgery or their ICU stay, while 93% of the patients
who underwent brain tumor surgeries received them. There
are no current recommendations regarding the routine
postoperative use of corticosteroids, which are administered
with the aim of reducing the brain edema associated with
resection. Nevertheless, corticosteroids are well known to
increase glucose levels, which may have contributed to our
findings.
We did not identify a significant association between
hyperglycemia and the three outcomes examined, which
may be explained by the small sample size and the
relatively few glucose measurements taken in the study
population. As hyperglycemia was common in this group,
special attention should be paid to it to prevent adverse
events, especially because other studies with larger series of
patients found a significant association between hypergly-
cemia and worse outcomes in surgical patients.
There were a few limitations associated with this study,
particularly due to the retrospective analytical design and
consequent lack of a previous protocol of glucose measure-
ment. Moreover, some of the surgery subgroups contained
few patients, which made it difficult to establish an
association between glucose levels and outcomes.
The treatment of hyperglycemia in pediatric intensive
care must be further analyzed, as there is no consensus on
the benefits of several procedures, such as insulin therapy
and strict glycemic control in these situations. In children,
organic components such as beta cells, liver, kidneys, and
muscles have not been exposed to oxidative, lipotoxic or
Table 1 - Glucose levels according to surgical diagnosis.
Diagnosis Glucose level at admission * Highest glucose level in 24 hours * Mean glucose level *
Ventriculoperitoneal shunting 135.4¡66.5 133.6¡38.5 117.9¡23.6
Craniostenosis 159.2¡69.9 150.4¡64.2 118¡39.9
Supratentorial brain tumors 160.5¡83.3 163.3¡47.9 131¡31.9
Infratentorial brain tumor 131.2¡30.8 151¡44.7 126.1¡36.9
Craniotomy for craniofacial dysostosis 161.8¡39.2 152.7¡14.2 155.1¡42.3
Spinal arthrodesis 149.8¡61.8 238¡172.5 112.2¡13.1
Epilepsy surgery 154.3¡41.1 138¡9.9 110.9¡11.9
Brain revascularization for arteriopathy 148¡28.3 N/E N/E
Spinal cord tumors 128.3¡30.1 N/E N/E
*Mean ¡ Standard Deviation (mg/dL).
N/E – Blood glucose measurement not evaluated due to the small number of samples.
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hyperglycemic stress for extended periods, and the effects
of hyperglycemia on these patients may differ from those
seen in adult populations.10-12 Therefore, changes in
glucose levels that develop after neurosurgery should be
better studied to outline preventive measures, such as
determination of glucose infusion rates, prevention of
unnecessary use of systemic corticosteroids, and early
diagnosis of infection.
CONCLUSIONS
Hyperglycemia is frequent in children following neuro-
surgery and was not found to be associated with the
durations of mechanical ventilation, PICU stay, or hospital
stay in this sample of pediatric patients. In pediatric
patients, glucose levels should be carefully and accurately
controlled after surgery, as this may reduce morbidity and
hospitalization time. Further studies are necessary to
elucidate the role of hyperglycemia in pediatric neurosurgi-
cal patients.
Table 2 - Results of univariate analysis.
Outcome Risk Factor Median SD N p-value
Fever
PICU LOS No 2.7 1.9 138 0.006
Yes 5.08 8.11 60
Hosp. LOS No 5.96 4.61 138 0.001
Yes 9.9 10.97 60
MV time No 5.83 8.49 138 ,0.001
Yes 8.48 11.57 60
Use of PRBC
PICU LOS No 3.13 2.94 102 0.468
Yes 3.73 6.26 96
Hosp. LOS No 7.23 6.79 102 0.623
Yes 7.08 7.95 96
MV time No 5.54 5.55 102 0.017
Yes 7.8 12.43 96
Laryngitis
PICU LOS No 2.9 2.29 168 0.027
Yes 6.33 10.89 30
Hosp. LOS No 6.6 5.66 168 0.059
Yes 10.3 13.06 30
MV time No 6.21 8.83 168 0.036
Yes 9.02 12.91 30
Coag. Disorders
PICU LOS No 3.32 4.82 189 0.065
Yes 5.44 5.05 9
Hosp. LOS No 7.08 7.4 189 0.247
Yes 8.78 6.4 9
MV time No 5.92 6.58 189 0.006
Yes 21.72 31.15 9
Inappropriate ADH
Syndrome
PICU LOS No 3.4 4.87 195 0.037
Yes 4.67 1.15 3
Hosp. LOS No 7.4 7.41 195 0.214
Yes 6.3 0.58 3
MV time No 6.61 9.64 195 0.022
Yes 8.33 1.15 3
Seizures
PICU LOS No 3.03 2.62 190 0.003
Yes 12.63 19.33 8
Hosp. LOS No 6.65 5.79 190 ,0.001
Yes 19.25 21.07 8
MV time No 6.56 9.75 190 0.002
Yes 8.5 3.02 8
Hyperglycemia
PICU LOS No 2.46 1.43 52 0.042
Yes 3.88 3.76 87
Hosp. LOS No 5.15 2.02 52 0.073
yes 8.46 7.49 87
MV time No 5.27 1.71 52 0.078
yes 9.74 15.6 87
CSF Leakage
PICU LOS No 3.24 4.72 192 0.001
yes 9.17 5.6 6
Hosp. LOS No 6.7 6.75 192 ,0.001
yes 21.67 11.47 6
MV time No 6.32 8.49 192 0.152
yes 16.83 27.05 6
ICH
PICU LOS No 2.97 2.54 189 ,0.001
yes 12.78 17.95 9
Hosp. LOS No 6.72 5.78 189 0.011
yes 16.33 21.14 9
MV time No 6.49 9.67 189 0.039
Yes 9.67 6.96 9
Infection
PICU LOS No 3.17 4.7 189 ,0.001
Yes 8.56 5.22 9
Hosp. LOS No 6.58 6.74 189 ,0.001
Yes 19.33 9.46 9
Outcome Risk Factor Median SD N p-value
MV time No 6.18 8.8 189 0.001
Yes 16.17 18.15 9
Hypothermia
PICU LOS No 3.5 5.14 166 0.65
Yes 3 2.86 32
Hosp. LOS No 7.37 7.8 166 0.365
Yes 6.06 4.28 32
MV time No 7.05 10.38 166 0.038
Yes 4.47 1.88 32
Legend – PICU LOS – Pediatric Intensive Care Unit Length of stay, SD –
standard deviation, MV – mechanical ventilation, PRBC – packed red
blood cells, CSF – cerebrospinal fluid, ICH – intracranial hypertension, ADH
– antidiuretic hormone.
Table 2 Cont.
Table 3 - Results of multivariate analysis.
Outcome Risk Factor Regression p-value
Analysis (Wald
Test)
PICU LOS Fever 7.72 ,0.001
Laryngitis 9.13 0.003
Hyperglycemia 3.2 0.062
Coagulation
disorders
0.23 0.63
Infection 4.1 0.043
Use of steroids 2.96 0.085
Fever 7.54 0.006
Laryngitis 3.39 0.066
Hospital LOS
Coagulation
disorders
0.31 0.576
Infection 8.99 0.003
Use of steroids 0.02 0.894
Fever 3.88 0.049
Laryngitis 4.29 0.038
MV time
Use of PRBC 5.27 0.022
Coagulation
disorders
14.11 ,0.001
Infection 2.36 0.125
Use of steroids 48.24 ,0.001
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